Imara to webcast conference call of first quarter 2021 financial results and business highlights

Boston, may 04, 2021 (globe newswire) -- imara inc. (nasdaq: imra), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin, today announced that the company will host a conference call and live webcast on tuesday, may 11, 2021 at 8:30 a.m. et to discuss its financial results for the quarter ended march 31, 2021 and review recent business highlights.
ELVN Ratings Summary
ELVN Quant Ranking